Works matching IS 22113428 AND DT 2024 AND VI 47 AND IP 1


Results: 21
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.

    Published in:
    Cellular Oncology (2211-3428), 2024, v. 47, n. 1, p. 189, doi. 10.1007/s13402-023-00862-1
    By:
    • Gutiérrez-Chamorro, Lucía;
    • Felip, Eudald;
    • Castellà, Eva;
    • Quiroga, Vanessa;
    • Ezeonwumelu, Ifeanyi Jude;
    • Angelats, Laura;
    • Esteve, Anna;
    • Perez-Roca, Laia;
    • Martínez-Cardús, Anna;
    • Fernandez, Pedro Luis;
    • Ferrando-Díez, Angelica;
    • Pous, Anna;
    • Bergamino, Milana;
    • Cirauqui, Beatriz;
    • Romeo, Marga;
    • Teruel, Iris;
    • Mesia, Ricard;
    • Clotet, Bonaventura;
    • Riveira-Muñoz, Eva;
    • Margelí, Mireia
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21